Extendicare Inc.

TSX:EXE.TO

Medical - Care Facilities

Healthcare
$28.81 +2.61%

+$0.86 today

Market cap
$2.74B
Beta
1.16
P/E (TTM)
26.4
EPS (TTM)
$1.28
Dividend yield
1.51%
52W Low $12.12High $35.62

Volume 0.86M

Average 0.34M

EXE.TO Depreciation & Amortization

Non-cash asset write-downs added back to net income because no cash left the business.

Extendicare Inc.TSX: EXE.TO

Depreciation & Amortization · Q2 FY2026 · quarter ended Jun 2026

Depreciation & amortization growth accelerates

Q2 FY2026 depreciation & amortization of CA$16.1M rose 89.8% year over year, ahead of the +37.1% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 59.4% from the prior quarter. Over 3 fiscal years it compounded at +5.1% a year.

Context

  • Depreciation & amortization amounted to 2.2% of revenue in FY2025, unchanged from a year earlier.
  • Depreciation & amortization increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +89.8% holds above the trailing-twelve-month pace of +37.1%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
CA$16.1M+59.4% QoQ
Last fiscal yearDec 2025
CA$37.25M+11.7% YoY
LTMJun 2026
CA$46.46M+37.1% YoY
Depreciation & Amortization past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+89.8%——
1 year+11.7%——
3-year CAGR+5.1%——
5-year CAGR——
10-year CAGR——

Depreciation & Amortization history

CAD · from the cash flow

Latest · FY2025
37.25M CAD
Year-over-year change
+11.7%
4-year CAGR
-0.9%

Depreciation & Amortization vs competitors

How EXE.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +37.1% is the highest of 7, against a peer median of -0.2%.
  • Depreciation & amortization amounts to 2.3% of revenue for EXE.TO, versus a peer median of 6.0%.
EXE.TO Competitors
Depreciation & Amortization for EXE.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
WELL.TOWELL Health Technologies Corp.LTM Mar 2026CA$99.79M CAD+32.5%+19.3%6.8%
TLRY.TOTilray Brands, Inc.LTM Feb 2026$82.34M USD-37.2%-4.8%9.6%
SIA.TOSienna Senior Living Inc.LTM Sep 2026CA$58.16M CAD+5.0%+7.8%5.2%
EXE.TOExtendicare Inc.LTM Jun 2026CA$46.46M CAD+37.1%+5.1%2.3%
CRRX.TOCareRx CorporationLTM Mar 2026CA$18.1M CAD-5.4%-3.0%4.8%
DR.TOMedical Facilities CorporationLTM Mar 2026$13.77M USD-26.6%-9.0%4.5%
CRON.TOCronos Group Inc.LTM Mar 2026$11.45M USD+9.6%+3.3%7.2%
Peer median (excluding EXE.TO) —-0.2%+0.2%6.0%

Competitors are the stored peer set for EXE.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income11.5M69.55M33.98M75.21M96.66M
Depreciation & Amortization38.57M32.12M32.23M33.34M37.25M
Deferred Income Tax6.61M(46K)4.01M23.86M(7.87M)
Stock-Based Compensation3.7M2.64M4.2M1.89M696K
Change in Working Capital9.29M54.06M(41.2M)22.85M57.02M
Accounts Receivables(13.77M)4.04M(29.2M)(3.58M)18.56M
Inventory(11.1M)0000
Accounts Payables11.1M48.62M(14.43M)31.92M25.24M
Other Working Capital23.05M1.4M2.43M(5.48M)13.22M
Other Non-Cash Items(10.59M)(59.46M)(9.94M)(13.51M)(18.54M)
Operating Cash Flow59.08M98.87M23.28M143.64M165.21M
Capital Expenditures(65.18M)(101.63M)(129.41M)(41.95M)(101.81M)
Acquisitions (Net)0253.14M00(75.12M)
Purchases of Investments0000(1.08M)
Sales of Investments00029.47M57.36M
Other Investing Activities5.79M4.13M44.96M3.37M1.63M
Investing Cash Flow(59.39M)155.64M(84.45M)(9.11M)(119.02M)
Debt Repayment(29.98M)(114.23M)18.67M(44.53M)30.61M
Common Stock Issued0000191.52M
Common Stock Repurchased0(35.02M)(11.06M)00
Dividends Paid(42.99M)(42.55M)(40.43M)(40.02M)(41.7M)
Other Financing Activities(1.86M)(56K)1.89M(3.31M)0
Financing Cash Flow(74.84M)(191.86M)(30.93M)(87.87M)180.43M
Effect of Forex Changes(184K)155K000
Net Change in Cash(75.33M)62.65M(92.1M)46.66M226.63M
Free Cash Flow(6.1M)(2.76M)(106.13M)101.69M63.4M

Extendicare Inc.

TSX:EXE.TO

Intrinsic Alpha fair value

Locked

Current Price

$28.81

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.